tiprankstipranks
Elixirr International Plc (GB:ELIX)
LSE:ELIX

Elixirr International Plc (ELIX) AI Stock Analysis

26 Followers

Top Page

GB:ELIX

Elixirr International Plc

(LSE:ELIX)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
959.00 p
▲(14.17% Upside)
Action:UpgradedDate:12/07/25
Elixirr International Plc's overall stock score is driven by its strong financial performance and positive corporate events, which highlight its growth trajectory and strategic positioning. However, bearish technical indicators suggest caution in the short term. The valuation is fair, supporting a balanced investment outlook.
Positive Factors
Strong revenue growth
Sustained >30% revenue growth indicates durable demand for Elixirr’s consulting services and successful client acquisition. Over 2–6 months this supports scale advantages, stronger client references, and reinvestment capacity to expand capabilities and win larger, higher‑margin engagements.
Negative Factors
Declining EPS
Negative EPS growth despite strong revenue expansion suggests margin pressure from investments, mix shifts, or dilution. Persisting EPS contraction can reduce per‑share returns and limit capacity to increase dividends or buybacks until profitability per share recovers.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained >30% revenue growth indicates durable demand for Elixirr’s consulting services and successful client acquisition. Over 2–6 months this supports scale advantages, stronger client references, and reinvestment capacity to expand capabilities and win larger, higher‑margin engagements.
Read all positive factors

Elixirr International Plc (ELIX) vs. iShares MSCI United Kingdom ETF (EWC)

Elixirr International Plc Business Overview & Revenue Model

Company Description
Elixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. It offers creative, marketing, and self-funded transformation services. The company offers...
How the Company Makes Money
Elixirr generates revenue primarily through its consulting services, charging clients for project-based work and ongoing advisory services. The company's revenue model is based on fees for consultancy projects, which can vary in complexity and dur...

Elixirr International Plc Financial Statement Overview

Summary
Elixirr International Plc demonstrates strong financial performance with robust revenue growth, efficient operations, and solid profitability. The company maintains a healthy balance sheet with low leverage and high equity, indicating financial stability and flexibility.
Income Statement
89
Very Positive
Balance Sheet
85
Very Positive
Cash Flow
87
Very Positive
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue129.72M111.34M85.89M71.75M50.61M30.32M
Gross Profit41.91M35.81M29.26M23.16M17.70M11.19M
EBITDA31.87M27.96M25.78M20.02M14.46M8.97M
Net Income18.56M16.38M17.24M12.87M10.14M4.79M
Balance Sheet
Total Assets170.17M175.89M154.40M128.66M107.17M87.00M
Cash, Cash Equivalents and Short-Term Investments2.84M7.53M18.13M20.43M31.80M17.50M
Total Debt14.15M4.90M5.36M5.14M5.25M5.29M
Total Liabilities50.06M43.78M34.84M32.74M21.13M16.31M
Stockholders Equity120.12M132.11M119.56M95.92M86.04M70.69M
Cash Flow
Free Cash Flow29.78M28.76M16.67M15.40M14.23M12.12M
Operating Cash Flow29.86M28.84M16.79M15.73M14.33M12.15M
Investing Cash Flow-26.08M-21.11M-14.82M-18.53M-3.24M-1.46M
Financing Cash Flow-23.26M-18.58M-4.06M-8.85M3.11M3.88M

Elixirr International Plc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price840.00
Price Trends
50DMA
687.51
Negative
100DMA
745.29
Negative
200DMA
753.94
Negative
Market Momentum
MACD
-28.48
Negative
RSI
35.94
Neutral
STOCH
44.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Negative. The current price of 840 is above the 20-day moving average (MA) of 630.10, above the 50-day MA of 687.51, and above the 200-day MA of 753.94, indicating a bearish trend. The MACD of -28.48 indicates Negative momentum. The RSI at 35.94 is Neutral, neither overbought nor oversold. The STOCH value of 44.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ELIX.

Elixirr International Plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
£2.87B19.4116.69%1.27%0.84%-62.73%
75
Outperform
£292.52M7.2814.71%2.13%32.67%-1.61%
70
Outperform
£195.26M10.476.46%3.68%15.99%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
60
Neutral
£90.60M7.606.42%8.80%6.04%-24.55%
56
Neutral
£539.39M24.999.94%1.19%9.25%-51.82%
41
Neutral
£328.67M-2.81-142.88%-4.87%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ELIX
Elixirr International Plc
602.00
33.13
5.82%
GB:CPI
Capita plc
274.50
95.10
53.01%
GB:GTLY
Gateley (Holdings)
66.00
-56.81
-46.26%
GB:DATA
GlobalData
76.60
-56.69
-42.53%
GB:SRP
Serco Group plc
291.40
143.24
96.68%
GB:YOU
Yougov plc
166.00
-103.33
-38.37%

Elixirr International Plc Corporate Events

Other
Elixirr Discloses Share Sale by Co-Founder’s Family Member, Ferguson Retains 4.5% Stake
Neutral
Jan 9, 2026
Elixirr International plc has disclosed that Amanda Ferguson, the wife of co-founder and board adviser Ian Ferguson, sold 2,998 ordinary shares in the company on 8 January 2026 at 834p per share. Following the transaction, Ian Ferguson remains ben...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025